Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Meta Platforms (Facebook)
META
|
+$742M |
| 3 |
Wells Fargo
WFC
|
+$363M |
| 4 |
Salesforce
CRM
|
+$310M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$869M |
| 2 |
Apple
AAPL
|
+$693M |
| 3 |
PPLI
People Inc
PPLI
|
+$488M |
| 4 |
Expedia Group
EXPE
|
+$409M |
| 5 |
Charter Communications
CHTR
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.04% |
| 2 | Healthcare | 2.79% |
| 3 | Financials | 2.32% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7626
Celldex Therapeutics
CLDX
$3.29B
| $373K | ﹤0.01% |
25,149
-34,359
| -58% | -$402K |
|
7627
PUT
ProShares UltraShort Energy
DUG
$18.1M
| $373K | ﹤0.01% |
+325
| New | +$290K |
|
7628
PUT
e.l.f. Beauty
ELF
$5.4B
| $373K | ﹤0.01% |
20,300
+3,000
| +17% | +$56.8K |
|
|
LX
7629
PUT
LexinFintech Holdings
LX
$224M
| $373K | ﹤0.01% |
54,400
+9,500
| +21% | +$82.6K |
|
7630
CALL
Ternium
TX
$10.6B
| $373K | ﹤0.01% |
19,800
-23,300
| -54% | -$391K |
|
7631
CALL
UFP Industries
UFPI
$4.96B
| $373K | ﹤0.01% |
6,600
+200
| +3% | +$11.3K |
|
|
VTLE
7632
DELISTED
Vital Energy
VTLE
| $373K | ﹤0.01% |
38,020
-18,848
| -33% | -$263K |
|
|
WMGI
7633
CALL
DELISTED
Wright Medical Group Inc
WMGI
| $373K | ﹤0.01% |
12,200
-27,100
| -69% | -$818K |
|
7634
Accenture
ACN
$108B
| $372K | ﹤0.01% |
1,646
-60,137
| -97% | -$13.8M |
|
7635
PUT
Avnet
AVT
$7.86B
| $372K | ﹤0.01% |
14,400
-4,100
| -22% | -$111K |
|
7636
CALL
Wave Life Sciences
WVE
$1.07B
| $372K | ﹤0.01% |
43,800
-13,500
| -24% | -$148K |
|
7637
PUT
Hercules Capital
HTGC
$3.13B
| $371K | ﹤0.01% |
32,100
+4,200
| +15% | +$46.7K |
|
7638
CALL
Methode Electronics
MEI
$608M
| $371K | ﹤0.01% |
+13,000
| New | +$375K |
|
|
ATNX
7639
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
| $371K | ﹤0.01% |
1,535
+600
| +64% | +$144K |
|
7640
CALL
Allot
ALLT
$383M
| $370K | ﹤0.01% |
40,700
+24,200
| +147% | +$256K |
|
7641
PUT
Broadridge
BR
$19.5B
| $370K | ﹤0.01% |
2,800
-11,700
| -81% | -$1.56M |
|
7642
First Bancorp
FBP
$4.53B
| $369K | ﹤0.01% |
70,594
-145,495
| -67% | -$810K |
|
7643
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$339M
| $369K | ﹤0.01% |
4,811
-10,869
| -69% | -$815K |
|
7644
SPX Corp
SPXC
$10.9B
| $369K | ﹤0.01% |
7,956
-1,474
| -16% | -$62.1K |
|
7645
PUT
Q32 Bio
QTTB
$451M
| $369K | ﹤0.01% |
+1,917
| New | +$430K |
|
|
ROCC
7646
CALL
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $369K | ﹤0.01% |
37,500
+3,100
| +9% | +$32.9K |
|
|
ASAP
7647
PUT
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $369K | ﹤0.01% |
5,735
+405
| +8% | +$33.7K |
|
|
ADVM
7648
PUT
DELISTED
Adverum Biotechnologies
ADVM
| $368K | ﹤0.01% |
3,570
+2,370
| +198% | +$355K |
|
7649
iShares Global Healthcare ETF
IXJ
$4.2B
| $368K | ﹤0.01% |
+5,119
| New | +$367K |
|
|
7650
PUT
Wave Life Sciences
WVE
$1.07B
| $368K | ﹤0.01% |
+43,400
| New | +$476K |
|
Similar funds
Ken Griffin's Q3 2020 Portfolio in Review
As of Q3 2020, Ken Griffin held 11,253 positions worth $353B, up 26% from $280B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin deployed $24.6B of net new capital in Q3 2020, opening 1,597 new positions and adding to 4,071 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Amazon, an estimated $869M trimmed.
- Ken Griffin's largest Q3 2020 buy was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $1.04B increase.
- Ken Griffin's biggest Q3 2020 reduction was Amazon, cutting an estimated $869M.
- Ken Griffin fully exited Intel in Q3 2020, selling an estimated $249M.
- Ken Griffin's ten largest holdings make up 36% of its $353B portfolio in Q3 2020.
- Ken Griffin opened 1,597 new positions and closed 1,263 in Q3 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $353B.
Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.